Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 4, 2011, Pages

  Gauthier, Kathryn M ^a   Olson, Lauren ^a   Harder, Adam ^a   Isbell, Marilyn ^a   Imig, John D ^a   Gutterman, David D ^a   Falck, J R ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arteries; EDHF; Epoxyeicosatrienoic acids; Hydrogen peroxide

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 14,15 DIHYDROXYEICOSATRIENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 4 [4 (3 ADAMANTAN 1 YL UREIDO)CYCLOCYCLOHEXYLOXY]BENZOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; 8,9 EPOXYICOSATRIENOIC ACID; AMITROLE; BIRD 0826; CATALASE; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; HYDROGEN PEROXIDE; HYDROLASE INHIBITOR; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; ENZYME ACTIVITY; HYDROLYSIS; MASS SPECTROMETRY; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASODILATATION;

EID: 80053364499     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00201.2011     Document Type: Article

References (31)

1. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, Platonov M, Koshal A, Hashimoto K, Campbell Falck JR WB, Michelakis ED. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKCa channels. Circulation 107: 769-776, 2003.
2. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 68: 26-36, 2005.
3. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
4. Campbell WB, Harder DR. Prologue: EDHF-what is it? Am J Physiol Heart Circ Physiol 280: H2413-H2416, 2001.
5. Chatterjee U, Sanwal GG. Purification and characterization of catalase from goat (Capra capra) lung. Mol Cell Biochem 126: 125-133, 1993.
6. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 92: 3337-3349, 1995.
7. Corey EJ, Niwa H, Falck JR. Selective epoxidation of eicosa-cis-5,8,11,14-tetraenoic (arachidonic) acid and eicosa-cis-8,11,14-trienoic acid. J Am Chem Soc 101: 1586-1587, 1979.
8. Enayetallah AE, French RA, Thibodeau MS, Grant DF. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52: 447-454, 2004.
9. Fleming I, Busse R. Endothelium-derived epoxyeicosatrienoic acids and vascular function. Hypertension 47: 629-633, 2006.
10. Fleming I, Rueben A, Popp R, Fisslthaler B, Schrodt S, Sander A, Haendeler J, Falck JR, Morisseau C, Hammock BD, Busse R. Epoxyeicosatrienoic acids regulate Trp-channel-dependent Ca signaling and hyperpolarization in endothelial cells. Arterioscler Thromb Vasc Biol 27: 2612-2618, 2007.
11. Furchgott RF, Zawadzki JW. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
12. Gao YJ, Lee RM. Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery. Br J Pharmacol 146: 1061-1068, 2005.
13. Guenthner TM, Hjelle JT, Whalen R. Selective inhibition of cytosolic epoxide hydrolase activity in vitro by compounds that inhibit catalase. J Biochem Toxicol 4: 241-249, 1989.
14. Guenthner TM, Qato M, Whalen R, Glomb S. Similarities between catalase and cytosolic epoxide hydrolase. Drug Metab Rev 20: 733-748, 1989.
15. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61: 866-879, 1987.
16. Imig JD, Navar LG, Roman RJ, Reddy KK, Falck JR. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7: 2364-2370, 1996.
17. Larsen BT, Gutterman DD, Sato A, Toyama K, Campbell WB, Zeldin DC, Manthati VL, Falck JR, Miura H. Hydrogen peroxide inhibits cytochrome P450 epoxygenases: interaction between two endothelium- derived hyperpolarizing factors. Circ Res 102: 59-67, 2008.
18. Larsen BT, Miura H, Hatoum OA, Campbell WB, Hammock BD, Zeldin DC, Falck JR, Gutterman DD. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels: implications for soluble epoxide hydrolase inhibition. Am J Physiol Heart Circ Physiol 290: H491-H499, 2006.
19. Li PL, Campbell WB. Epoxyeicosatrienoic acids activate K_ channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ Res 80: 877-884, 1997.
20. Maimoni GV, Cezar de Cerqueira LL, Raw I, Cabrera-Crespo J. Purification of catalase from human placenta. Biotechnol Appl Biochem 29: 73-77, 1999.
21. Matoba T, Shimokawa H, Morikawa K, Kubota H, Kunihiro I, Urakami-Harasawa L, Mukai Y, Hirakawa Y, Akaike T, Takeshita A. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol 23: 1224-1230, 2003.
22. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2106: 1521-1530, 2000.
23. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30: 293-331, 1979.
24. Morikawa K, Fujiki T, Matoba T, Kubota H, Hatanaka M, Takahashi S, Shimokawa H. Important role of superoxide dismutase in EDHFCATALASE mediated responses of human mesenteric arteries. J Cardiovasc Pharmacol 44: 552-556, 2004.
25. Morikawa K, Shimokawa H, Matoba T, Kubota H, Akaike T, Talukder MA, Hatanaka M, Fujiki T, Maeda H, Takahashi S, Takeshita A. Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest 112: 1871-1879, 2003.
26. Nithipatikom K, Grall AJ, Holmes BB, Harder DR, Falck JR, Campbell WB. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal Biochem 298: 327-336, 2001.
27. Pinto A, Abraham NG, Mullane KM. Arachidonic acid-induced endothelial-dependent relaxation of canine coronary arteries: contribution of a cytochrome P450-dependent pathway. J Pharmacol Exp Ther 240: 856-863, 1987.
28. Roslowsky M, Campbell WB. Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol Heart Circ Physiol 264: H327-H335, 1993.
29. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD, Zeldin DC, Kroetz DL. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87: 992-998, 2000.
30. Zeldin DC, Kobayashi J, Falck JR, Winder BS, Hammock BD, Snapper JR, Capdevila JH. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem 268: 6402-6407, 1993.
31. +-channel activity. Am J Physiol Renal Fluid Electrolyte Physiol 270: F822-F832, 1996.